Strategic workshops on cancer nanotechnology

Larry A. Nagahara, Jerry S.H. Lee, Linda K. Molnar, Nicholas J. Panaro, Dorothy Farrell, Krzysztof Ptak, Joseph Alper, Piotr Grodzinski*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Nanotechnology offers the potential for new approaches to detecting, treating, and preventing cancer. To determine the current status of the cancer nanotechnology field and the optimal path forward, the National Cancer Institute's Alliance for Nanotechnology in Cancer held three strategic workshops, covering the areas of in vitro diagnostics and prevention, therapy and post-treatment, and in vivo diagnosis and imaging. At each of these meetings, a wide range of experts from academia, industry, the nonprofit sector, and the U.S. government discussed opportunities in the field of cancer nanotechnology and barriers to its implementation.

Original languageEnglish
Pages (from-to)4265-4268
Number of pages4
JournalCancer Research
Issue number11
StatePublished - 1 Jun 2010
Externally publishedYes


Dive into the research topics of 'Strategic workshops on cancer nanotechnology'. Together they form a unique fingerprint.

Cite this